Disrupted copper availability in sporadic ALS: Implications for CuII(atsm) as a treatment option
James B. W. Hilton, Kai Kysenius, Jeffrey R. Liddell, Stephen W. Mercer, Bence T. Paul, Joseph S. Beckman, Catriona McLean, Anthony Robert White, Paul S. Donnelly, Ashley Ian Bush, Dominic James Hare, Blaine Russell Roberts, Peter John Crouch
The paper investigates copper availability in sporadic ALS and suggests CuII(atsm) may be therapeutically relevant by improving copper bioavailability.
Scientific Reports · Mar 11, 2024Peer-reviewedNeuroscience